Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
IJU Case Reports|May 18, 2026
Concurrent Bladder Urothelial Carcinoma and Prostate Tuberculosis: A Case ReportRikuo Suzuki, Taketo Kawai
International Journal of Urology : Official Journal of the Japanese Urological Association|December 5, 2016
Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological AssociationTaketo Kawai, Yoshinori Tanaka,
Japanese Journal of Clinical Oncology|March 15, 2025
Local therapy for oligometastatic prostate cancerTaketo Kawai, Satoru Taguchi, Tohru Nakagawa, et al.
Japanese Journal of Clinical Oncology|December 18, 2023
Latest evidence on clinical outcomes and prognostic factors of advanced urothelial carcinoma in the era of immune checkpoint inhibitors: a narrative reviewSatoru Taguchi, Taketo Kawai, Tohru Nakagawa, et al.
Advances in Therapy|November 29, 2025
Real-World Treatment Patterns in Patients with Metastatic Castration-Sensitive Prostate Cancer in Japan: A Retrospective Health Administrative Data AnalysisTaketo Kawai, Fumiko Kiyonaga, Hirotaka Shibata, et al.
Urology Case Reports|March 9, 2016
Adenoma-carcinoma Sequence in the Bladder After Augmentation CystoplastyAkihiro Naito, Taketo Kawai, Tetsuya Fujimura, et al.
International Journal of Clinical and Experimental Pathology|July 5, 2013
UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomyTeppei Morikawa, Taketo Kawai, Hiroyuki Abe, et al.
IJU Case Reports|July 5, 2024
Myelodysplastic syndrome occurring after enfortumab vedotin treatment for metastatic urothelial carcinomaKazuki Yanagida, Taketo Kawai, Toyoshi Seito, et al.
Cancers|April 27, 2024
In Curative Stereotactic Body Radiation Therapy for Prostate Cancer, There Is a High Possibility That 45 Gy in Five Fractions Will Not Be Tolerated without a Hydrogel SpacerSubaru Sawayanagi, Hideomi Yamashita, Mami Ogita, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 26, 2026
Safety and efficacy of moderately hypofractionated radiotherapy after radical prostatectomy: A phase II trialSubaru Sawayanagi, Hideomi Yamashita, Taketo Kawai, et al.
Pageof 13